4D Molecular Therapeutics, Inc.
FDMT · NASDAQ
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | August 7, 2026 | — | 3.10M | — | -1.04 | — |
| 2026 Q1 | May 7, 2026 | 3.05M | 2.59M | -1.01 | -0.97 | — |
| 2025 Q4 | March 18, 2026 | 85.10M | 27.00M | 0.43 | -0.53 | +7.20% |
| 2025 Q3 | November 10, 2025 | 90.00K | 30.86M | -1.01 | -1.02 | -6.29% |
| 2025 Q2 | August 11, 2025 | 15.00K | 4.67K | -0.98 | -0.88 | +2.25% |
| 2025 Q1 | May 8, 2025 | 14.00K | 537.50K | -0.86 | -0.84 | -4.94% |
| 2024 Q4 | February 28, 2025 | 1.00K | 2.28M | -0.90 | -0.80 | — |
| 2024 Q3 | November 13, 2024 | 3.00K | 2.20M | -0.79 | -0.67 | +10.10% |
| 2024 Q2 | August 8, 2024 | 5.00K | 1.31M | -0.63 | -0.72 | — |
| 2024 Q1 | May 9, 2024 | 28.00K | 780.00K | -0.66 | -0.73 | -2.62% |
| 2023 Q4 | February 29, 2024 | 19.00K | 2.40M | -0.77 | -0.68 | — |
| 2023 Q3 | November 9, 2023 | 20.20M | 2.06M | -0.24 | -0.67 | -0.27% |
| 2023 Q2 | August 9, 2023 | 239.00K | 850.00K | -0.77 | -0.77 | +0.48% |
| 2023 Q1 | May 10, 2023 | 298.00K | 1.03M | -0.88 | -0.88 | +5.98% |
| 2022 Q4 | March 15, 2023 | 1.25M | 3.01M | -0.84 | -0.75 | — |
| 2021 Q4 | March 28, 2022 | 92.00K | 900.00K | -0.85 | -0.82 | -8.41% |